TY - JOUR
T1 - Acute Treatment of Migraine
AU - Vargas, Bert B.
N1 - Publisher Copyright:
© 2018 Lippincott Williams & Wilkins.
PY - 2018/8/1
Y1 - 2018/8/1
N2 - Purpose of Review: This article provides a framework to help providers formulate a plan for the acute treatment of migraine. Topics covered include the cost-effective patient-centered approach known as stratified care and a summary of evidence-based treatment options that are currently available. Strategies for improving treatment response, troubleshooting suboptimal results, and addressing the needs of special populations are also reviewed. Recent Findings: Both the American Headache Society and the Canadian Headache Society have released evidence-based assessments and reviews of acute treatments for migraine that can be used to help guide treatment decisions. Although several older medications have been re-released with new formulations or new delivery systems, several new medications have also become available or are in the final phases of study, further increasing the number of options available for patients. Summary: The acute management of migraine should incorporate a stratified care model in concert with evidence-based treatment options. The response to treatment should be monitored regularly, and measures should be taken to identify suboptimal tolerability or efficacy.
AB - Purpose of Review: This article provides a framework to help providers formulate a plan for the acute treatment of migraine. Topics covered include the cost-effective patient-centered approach known as stratified care and a summary of evidence-based treatment options that are currently available. Strategies for improving treatment response, troubleshooting suboptimal results, and addressing the needs of special populations are also reviewed. Recent Findings: Both the American Headache Society and the Canadian Headache Society have released evidence-based assessments and reviews of acute treatments for migraine that can be used to help guide treatment decisions. Although several older medications have been re-released with new formulations or new delivery systems, several new medications have also become available or are in the final phases of study, further increasing the number of options available for patients. Summary: The acute management of migraine should incorporate a stratified care model in concert with evidence-based treatment options. The response to treatment should be monitored regularly, and measures should be taken to identify suboptimal tolerability or efficacy.
UR - http://www.scopus.com/inward/record.url?scp=85051129894&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051129894&partnerID=8YFLogxK
U2 - 10.1212/CON.0000000000000639
DO - 10.1212/CON.0000000000000639
M3 - Review article
C2 - 30074548
AN - SCOPUS:85051129894
SN - 1080-2371
VL - 24
SP - 1032
EP - 1051
JO - CONTINUUM Lifelong Learning in Neurology
JF - CONTINUUM Lifelong Learning in Neurology
IS - 4-Headache
ER -